H

Hospital Mãe de Deus | Clinical Research of Oncology and Hematology

Research site

(Unclaimed)

Location

Rua Costa, 30, Porto Alegre, Rio Grande do Sul, Brazil

Site insights

Top conditions

Top treatments

AGEN2034

Leronlimab

Tisotumab

Gemcitabine

5-Fluorouracil

Lactase

Dapagliflozin

Rofecoxib

DP-b99

Cetuximab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 23 total trials

A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer that has spread through t...

Enrolling

Carcinoma, Non-Small-Cell Lung

Drug: sigvotatug vedotin

Drug: docetaxel

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipi...

Active, not recruiting

Stroke

Myocardial Infarction

Drug: Evolocumab

Drug: Routine Lipid Management

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

This is a randomized, blinded, non-comparative, two-arm Phase 2 clinical trial to assess the efficacy and safety of AGEN2034 administered with placeb...

Active, not recruiting

Cervical Cancer

Drug: AGEN2034

Drug: AGEN1884

Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)

This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cer...

Active, not recruiting

Cervical Cancer

Drug: topotecan

Drug: gemcitabine